Autologous Stem Cell Transplantation may be Curative for Patients with Follicular Lymphoma with Early Therapy Failure without the need for Immunotherapy

ConclusionASCT may be a curative option for ETF in patients who respond to rescue chemotherapy, without the need for immunotherapy or other therapies, and should be considered as an early consolidation, especially in patients with difficult access to rituximab.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research